Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Vogtareuth

6 clinical trials in Vogtareuth, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Vogtareuth at a glance
6
clinical trials
  • Not yet recruiting0
  • Research sites1
Type of trial
Recruitment status
Quick filters

6 trials in Vogtareuth

Open in trial search

Rett syndrome

Recruiting
Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Fenfluramine Hydrochloride
  • Sponsor:UCB Biosciences Inc.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Longboard Pharmaceuticals Inc.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Longboard Pharmaceuticals Inc.
Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Fenfluramine Hydrochloride
  • Sponsor:Zogenix International Limited
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Soticlestat
  • Sponsor:Takeda Development Center Americas Inc.
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Fenfluramine Hydrochloride
  • Sponsor:Universitaetsklinikum Schleswig-Holstein AöR

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Vogtareuth

What the registry says about research in the country

01 Neurological Disorders

Investigating advanced therapies for rare neurological conditions, focusing on Dravet Syndrome and Lennox-Gastaut Syndrome. Research evaluates long-term safety of innovative treatments alongside standard care options.

  • Adjunctive Therapy Development
  • Long-term Safety Assessment
  • Treatment Tolerability

Studies incorporate various treatment approaches including medication, vagus nerve stimulation, and dietary interventions.

02 Genetic Disorders

Clinical research examining therapeutic interventions for CDKL5 Deficiency Disorder, a rare genetic condition. The trials focus on evaluating new treatment options for both pediatric and adult populations.

  • Medication Efficacy Testing
  • Age-Specific Response Analysis
  • Safety Monitoring

Comprehensive studies comparing new therapeutic compounds against placebo in controlled settings.

03 Pediatric Neurology

Specialized research targeting rare neurological conditions affecting children and young adults. Studies focus on developmental disorders and their long-term management.

  • Novel Treatment Approaches
  • Extended Safety Evaluation
  • Quality of Life Assessment

Research aims to advance understanding of rare neurological conditions while developing safer, more effective treatments.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.